UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID‐19 practice change

European journal of haematology, 2023-07, Vol.111 (1), p.154-160

2023

Volltextzugriff (PDF)

Impact of Obesity on Lumbar Puncture Outcomes in Adults with Acute Lymphoblastic Leukemia and Lymphoma: Experience at an Academic Reference Center

International journal of hematology- oncology and stem cell research, 2019-07, Vol.13 (3), p.146-152

2019

Volltextzugriff (PDF)

ABCL-598 Real-World Application of the CNS-IPI in the Management of Central Nervous System Prophylaxis for Patients With Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: A Single-Center Experience

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S485-S485

2024

Volltextzugriff (PDF)

ABCL-327 Anatomical Pattern of CNS Relapse in Aggressive B-cell Lymphomas

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S472-S473

2024

Volltextzugriff (PDF)

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

Annals of hematology, 2011-07, Vol.90 (7), p.809-818

2011

Volltextzugriff (PDF)

Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?

Blood reviews, 2023-09, Vol.61, p.101101, Article 101101

2023

Volltextzugriff (PDF)

Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement

Leukemia research, 2024-02, Vol.137, p.107452, Article 107452

2024

Volltextzugriff (PDF)

ABCL-044 Utility of CNS Prophylaxis in Diffuse Large B-Cell Lymphoma Patients – A Single Institution Experience From Pakistan

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S455-S455

2024

Volltextzugriff (PDF)

The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report

Frontiers in oncology, 2024-07, Vol.14, p.1402970

2024

Volltextzugriff (PDF)

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

British journal of haematology, 2020-09, Vol.190 (5), p.708-714

2020

Volltextzugriff (PDF)

Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse

Leukemia & lymphoma, 2019-07, Vol.60 (8), p.1890-1898

2019

Volltextzugriff (PDF)

Management of secondary central nervous system lymphoma

British journal of haematology, 2023-01, Vol.200 (2), p.160-169

2023

Volltextzugriff (PDF)

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

British journal of haematology, 2019-10, Vol.187 (2), p.185-194

2019

Volltextzugriff (PDF)

Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant

Leukemia & lymphoma, 2022-08, Vol.63 (10), p.2444-2452

2022

Volltextzugriff (PDF)

ALL-326: Low Incidence of Central Nervous System (CNS) Relapse with Hyper-CVAD-R Regimen in Adults with Burkitt Lymphoma/Leukemia (BL) and High-Grade B-Cell Lymphoma (HGBCL)

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S170-S171

2020

Volltextzugriff (PDF)

The ASPHO 2023 Distinguished Career Award goes to Dr. A. Kim Ritchey

Pediatric blood & cancer, 2023-06, Vol.70 (6), p.e30329-n/a

Hastings, Caroline

2023

Volltextzugriff (PDF)

CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?

Frontiers in neurology, 2023-04, Vol.14, p.1144414-1144414

2023

Volltextzugriff (PDF)

Evaluation of Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia (ALL) Receiving Hyper-CVAD Treatment in Seyyed Al-Shohada Hospital: Isfahan, 2014-2019

International journal of hematology- oncology and stem cell research, 2024, Vol.18 (1), p.47-52

2024

Volltextzugriff (PDF)

Multimodality treatment for recurrent neuroblastoma in the central nervous system

Pediatric blood & cancer, 2023-04, Vol.70 (4), p.e30227-n/a

2023

Volltextzugriff (PDF)

MCL-247: Durable Response of a Patient with a Mantle Cell Lymphoma Central Nervous System (CNS) Relapse to Treatment with a Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S259-S260

2020

Volltextzugriff (PDF)

The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis

Critical reviews in oncology/hematology, 2022-08, Vol.176, p.103756-103756, Article 103756

2022

Volltextzugriff (PDF)

Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study

British journal of haematology, 2023-02, Vol.200 (4), p.440-450

2023

Volltextzugriff (PDF)

Late isolated central nervous system relapse in childhood B‐cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2

Pediatric blood & cancer, 2021-12, Vol.68 (12), p.e29256-n/a

2021

Volltextzugriff (PDF)

Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures

World neurosurgery, 2023-11, Vol.179, p.e387-e396

2023

Volltextzugriff (PDF)

1 – 25 von 434

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(387)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(367)
Life Sciences & Biomedicine
(366)
Male
(255)
Humans
(243)
Relapse
(239)
Biological And Medical Sciences
(238)
Medical Sciences
(238)
Pharmacology. Drug Treatments
(214)
Psychopharmacology
(203)
Neuropharmacology
(202)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(202)
Psychology. Psychoanalysis. Psychiatry
(202)
Female
(169)
Psychiatry
(151)
Recurrence
(135)
Neurosciences & Neurology
(127)
Oncology
(123)
Cns Relapse
(121)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer
(119)
Adult
(116)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID‐19 practice change

Impact of Obesity on Lumbar Puncture Outcomes in Adults with Acute Lymphoblastic Leukemia and Lymphoma: Experience at an Academic Reference Center

ABCL-598 Real-World Application of the CNS-IPI in the Management of Central Nervous System Prophylaxis for Patients With Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: A Single-Center Experience

ABCL-327 Anatomical Pattern of CNS Relapse in Aggressive B-cell Lymphomas

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?

Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement

ABCL-044 Utility of CNS Prophylaxis in Diffuse Large B-Cell Lymphoma Patients – A Single Institution Experience From Pakistan

The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse

Management of secondary central nervous system lymphoma

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant

ALL-326: Low Incidence of Central Nervous System (CNS) Relapse with Hyper-CVAD-R Regimen in Adults with Burkitt Lymphoma/Leukemia (BL) and High-Grade B-Cell Lymphoma (HGBCL)

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy

The ASPHO 2023 Distinguished Career Award goes to Dr. A. Kim Ritchey

CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?

Evaluation of Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia (ALL) Receiving Hyper-CVAD Treatment in Seyyed Al-Shohada Hospital: Isfahan, 2014-2019

Multimodality treatment for recurrent neuroblastoma in the central nervous system

MCL-247: Durable Response of a Patient with a Mantle Cell Lymphoma Central Nervous System (CNS) Relapse to Treatment with a Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy

The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis

Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study

Late isolated central nervous system relapse in childhood B‐cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2

Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures

Suchergebnisse filtern